Boditech Med financials at a glance

+ Portfolio

The revenue of Boditech Med is reported as 135.18384 billion Won in the fiscal year 2023. The earnings were 1160 Won per share in 2023, which was 2806.85 higher than 2018. And about 15.64535 billion Won are reported as free cash flow in the financials of Boditech Med 2023. Dividends of 150 Won per share were paid to shareholders of Boditech Med stock KOSDAQ:A206640 in fiscal 2023.

Forecast

Financials

Year	Year	TTM	2020	2018	2017	2016	2015
Rev.	Revenue	N/A	₩144.13B	₩66.20B	₩52.59B	₩54.97B	₩39.82B
GM %	Gross Margin %	60.38%	67.60%	49.71%	55.69%	62.49%	66.74%
OM	Operating Margin	22.94%	45.80%	9.81%	5.46%	22.53%	31.08%
EPS	Earnings Per Share	₩1.18k	₩1.98k	₩-73.00	₩-93.00	₩543.64	₩-90.91
Div.	Dividends	N/A	₩0.00	₩0.00	₩50.00	₩90.91	₩0.00
PR %	Payout Ratio %	0	0	0	-53.76%	16.72%	0
Sha.	Shares	N/AM	23.04M	23.14M	23.02M	23.03M	229.2M
OCF	Operating Cash Flow	N/A	₩0.00M	₩0.00M	₩886.74M	₩11.79B	₩10.50B
FCF	Free Cash Flow	N/A	₩0.00M	₩0.00M	₩-5,096.68M	₩3.56B	₩277.65M
FCFS	Free Cash Flow Per Share	₩1.15k	₩1.75k	₩70.06	₩-,251.50	₩86.27	₩-41.00

Boditech Med financials at a glance

Financials

Discover